Nomura Asset Management Co. Ltd. Has $2.52 Million Stock Position in Teleflex Incorporated (NYSE:TFX)

Nomura Asset Management Co. Ltd. grew its position in shares of Teleflex Incorporated (NYSE:TFX) by 0.9% in the 4th quarter, HoldingsChannel reports. The fund owned 14,140 shares of the medical technology company’s stock after buying an additional 125 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Teleflex were worth $2,517,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the company. Norges Bank bought a new stake in Teleflex during the 4th quarter valued at $100,328,000. Diamond Hill Capital Management Inc. bought a new stake in shares of Teleflex during the fourth quarter worth about $46,696,000. Magnetar Financial LLC lifted its position in Teleflex by 105.2% in the 4th quarter. Magnetar Financial LLC now owns 421,340 shares of the medical technology company’s stock valued at $74,990,000 after acquiring an additional 215,961 shares in the last quarter. Cooke & Bieler LP boosted its stake in Teleflex by 22.1% during the 4th quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company’s stock valued at $191,962,000 after purchasing an additional 195,150 shares during the last quarter. Finally, Boston Partners increased its holdings in Teleflex by 1,561.5% during the 4th quarter. Boston Partners now owns 148,042 shares of the medical technology company’s stock worth $26,351,000 after purchasing an additional 139,132 shares in the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Stock Up 0.6 %

Shares of NYSE TFX opened at $141.13 on Thursday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The stock has a market capitalization of $6.54 billion, a PE ratio of 28.06, a P/E/G ratio of 1.73 and a beta of 1.21. Teleflex Incorporated has a one year low of $128.55 and a one year high of $249.91. The business’s fifty day moving average price is $156.70 and its 200-day moving average price is $188.17.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03. The firm had revenue of $795.40 million during the quarter, compared to analyst estimates of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. On average, equities research analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a yield of 0.96%. Teleflex’s payout ratio is 95.77%.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. Raymond James cut Teleflex from an “outperform” rating to a “market perform” rating in a research report on Friday, February 28th. Truist Financial reduced their target price on shares of Teleflex from $200.00 to $149.00 and set a “hold” rating for the company in a research note on Monday, March 3rd. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a report on Wednesday, March 12th. Piper Sandler reaffirmed a “neutral” rating and issued a $140.00 price objective (down from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Finally, Bank of America cut shares of Teleflex from a “neutral” rating to an “underperform” rating and dropped their target price for the stock from $235.00 to $140.00 in a research report on Tuesday, March 4th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $182.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.